Abstract
It is clear in Literature the effectiveness of HPV (Human Papilloma Virus) vaccine in women when administered before first sexual intercourse whit reduced benefit in those who are already HPV positive. What remains to be clarified is whether the HPV vaccines have any impact on HPV infections and any benefit in women who have been previously treated for pre-invasive cervical disease. HPV vaccine is currently indicated as preventive tool for cervical cancer, cervical and vulvar dysplasia and also genital warts. So it is possible to assume that it could play a preventive role against clinical relapses of these diseases. The aim of our study is evaluate the feasibility of HPV quadrivalent vaccine in an Italian cohort of women under 45 years of age whit previous history of CIN and evaluate the effectiveness of HPV vaccine as a tool also to prevent recurrent disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
